4-[3-(TRANS-3-DIMETHYLAMINOCYCLOBUTYL)-1H-INDOL-5-YLMETHYL]-4(S)OXAZOLIDIN-2-ONE MONOBENZOATE AND SULPHATE SALT - Patent 0842173

(19)

(11)

EP 0 842 173 A1

(12)

(43)	Date of publication:
	20.05.1998 Bulletin 1998/21

(21)	Application number: 96926370.0

(22)	Date of filing: 19.07.1996

(51)

International Patent Classification (IPC):

A61K 31/ 00^{( . )}
A61K 31/ 403^{( . )}
A61P 25/ 06^{( . )}

A61K 31/ 40^{( . )}
A61K 31/ 404^{( . )}
C07D 413/ 06^{( . )}

(86)	International application number:
	PCT/EP1996/003188

(87)	International publication number:
	WO 1997/003983 (06.02.1997 Gazette 1997/07)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30)

Priority:

22.07.1995 GB 19950015060

(71)	Applicant: GLAXO GROUP LIMITED
	Greenford, Middlesex UB6 0NN (GB)

(72)	Inventors:
	SELWOOD, David, Lawrence Hertfordshire AL7 2HL (GB) BROCKWELL, Michael, John Beckenham, Kent BR3 3BS (GB)

(74)	Representative: Hesketh, Alan, et al
	Glaxo Wellcome plc Glaxo Wellcome House, Berkeley Avenue Greenford, Middlesex UB6 0NN Greenford, Middlesex UB6 0NN (GB)

(54)	4-[3-(TRANS-3-DIMETHYLAMINOCYCLOBUTYL)-1H-INDOL-5-YLMETHYL]-4(S)OXAZOLIDIN-2-ONE MONOBENZOATE AND SULPHATE SALT